By Sabela Ojea Cidara Therapeutics said REZZAYO (rezafungin acetate), its treatment for invasive candidiasis in adults, has been approved by the U.K.'s.
By Ben Glickman Regeneron Pharmaceuticals and Sanofi's Dupilumab received approval from the U.S. Food and Drug Administration for a treatment of an esophagus.
By Colin Kellaher U.S.-listed shares of Theratechnologies tumbled in premarket trading Wednesday after the Food and Drug Administration turned away an.
By Colin Kellaher The U.S. Food and Drug Administration has rejected an application from Theratechnologies seeking approval of a newer formulation of its.
By Chris Wack Heron Therapeutics shares were up 15% to $2.53 after the U.S. Food and Drug Administration approved its supplemental new drug application for.